Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coinbase Global | Xetra | Technology | Financial Technology (Fintech) & Infrastructure | 119.7% | €89.01B | 69.2x | 13.74 | €350.25 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ProQR Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | 99.5% | €218.06M | -6.3x | 4.1 | €1.97 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ceres Power | Frankfurt | Energy | Renewable Energy | 85.3% | €228.99M | -6.9x | -0.14 | €1.06 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax | Frankfurt | Healthcare | Biotechnology & Medical Research | 77.5% | €548.40M | -3x | -0.25 | €8.52 | -7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curevac | Frankfurt | Healthcare | Biotechnology & Medical Research | 70.2% | €1.05B | 5.8x | 0.04 | €4.68 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Xetra | Healthcare | Biotechnology & Medical Research | 70.2% | €1.05B | 5.8x | 0.04 | €4.65 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philomaxcap | Frankfurt | Technology | Financial Technology (Fintech) & Infrastructure | 68.4% | €143.43M | -4.5x | 0.58 | €1.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Frankfurt | Healthcare | Pharmaceuticals | 57.9% | €42.63M | -4.5x | 0.08 | €0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueprint Medicines | Frankfurt | Healthcare | Biotechnology & Medical Research | 54.3% | €7.22B | -52.7x | -1.12 | €110.05 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cosmo Pharmaceuticals NV | Frankfurt | Healthcare | Pharmaceuticals | 38.8% | €1.06B | 8.1x | 0.01 | €67.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dominari | Frankfurt | Financial | Investment Banking & Investment Services | 26.6% | €70.79M | -1x | 0.08 | €4.64 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kinnevik B | Frankfurt | Financial | Investment Holding Companies | 21.7% | €2.31B | -10.1x | -0.15 | €8.11 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invesco Mortgage Capital | Frankfurt | 16% | €427.99M | 15.6x | 0.1 | €6.39 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Axsome Therapeutics | Frankfurt | Healthcare | Pharmaceuticals | 1.8% | €4.80B | -19.6x | -1.98 | €94.62 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
2Invest | Frankfurt | Financial | Investment Holding Companies | 0% | €66.73M | 3x | 0 | €12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
2Invest | Xetra | Financial | Investment Holding Companies | -0.8% | €66.73M | 3x | 0 | €12.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beta Systems Software | Frankfurt | Technology | Software & IT Services | -10.9% | €75.72M | 1.1x | 0 | €15.70 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
11 Bit Studios | Frankfurt | Technology | Software & IT Services | -11.1% | €103.10M | 206.8x | 1.29 | €42.12 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MPH Health Care AG | Xetra | Healthcare | Pharmaceuticals | -19.5% | €84.99M | 2.7x | 0.3 | €19.85 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MPH Health Care AG | Frankfurt | Healthcare | Pharmaceuticals | -21.9% | €84.99M | 2.7x | 0.31 | €19.35 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |